On-Label HCV Treatment Works Better Than Off-Label, Analysis Shows
This article was originally published in The Pink Sheet Daily
Executive Summary
A difference of at least 10% was seen in treatment outcomes for patients treated on-label for HCV across three different drug regimens compared to those treated outside of label guidance, according to Trio Health.